Related Experiment Videos
BLT-esterase in infectious mononucleosis
L Wagner1, M Wiesholzer, C P Worman
1Department of Medicine III, University of Vienna, Austria.
Clinical and Experimental Immunology
|May 1, 1995
Summary
Infectious mononucleosis patients show high BLT-esterase levels in lymphocytes during acute illness. This enzyme may aid immune defense against Epstein-Barr virus (EBV) by targeting infected B cells.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Infectious mononucleosis (IM) is a common viral illness caused by Epstein-Barr virus (EBV).
- The immune response to EBV involves complex lymphocyte dynamics.
- BLT-esterase, a cytochemical marker, has been investigated in various immune conditions.
Purpose of the Study:
- To investigate the expression of BLT-esterase in peripheral blood lymphocytes during acute infectious mononucleosis.
- To correlate BLT-esterase expression with clinical symptoms and laboratory findings.
- To explore the potential role of BLT-esterase in the immune response to EBV.
Main Methods:
- Cytochemical staining for BLT-esterase expression in peripheral blood lymphocytes.
- Immunocytochemical phenotype analysis of lymphocyte subsets (CD4, CD8, CD19, DR).
- Analysis of clinical data and hepatocellular enzyme levels.
Main Results:
- A significant increase in BLT-esterase-expressing lymphocytes (up to 90%) was observed during the acute phase of IM.
- Elevated BLT-esterase levels correlated with symptom severity and peak hepatocellular enzymes.
- BLT-esterase expression decreased gradually during recovery, coinciding with reduced CD8+ DR+ lymphocytes.
- 95% of CD8+ lymphocytes were found to be BLT-esterase-positive.
Conclusions:
- BLT-esterase is highly expressed on lymphocytes during acute EBV infectious mononucleosis.
- BLT-esterase may play a role in the immune defense against EBV, potentially by inducing apoptosis in EBV-infected B cells.